Radiance Therapeutics
Founded Year
2018Stage
Debt - II | AliveTotal Raised
$14.01MLast Raised
$4.29M | 3 yrs agoAbout Radiance Therapeutics
Radiance Therapeutics is commercializing a clinically demonstrated anti-metabolite therapy for glaucoma drainage surgery. Its Beta Ophthalmic System is designed to apply beta therapy to the surgical site to down-regulate fibroblasts that cause scar tissue, keeping the channel open and maintaining reduced intraocular pressure.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Radiance Therapeutics's Product Videos
Radiance Therapeutics's Products & Differentiators
RadianceTx’s Beta Ophthalmic System®
A beta medical device for glaucoma surgery: it applies beta therapy to the surgical site to down-regulate fibroblasts that cause scar tissue to keep the drainage channel open and maintaining reduced IOP.
Radiance Therapeutics Patents
Radiance Therapeutics has filed 12 patents.
The 3 most popular patent topics include:
- Diseases of the eye and adnexa
- Radioactivity
- Glaucoma
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
9/26/2019 | 6/6/2023 | Diseases of the eye and adnexa, Eye surgery, Ophthalmology, Glaucoma, Rare diseases | Grant |
Application Date | 9/26/2019 |
|---|---|
Grant Date | 6/6/2023 |
Title | |
Related Topics | Diseases of the eye and adnexa, Eye surgery, Ophthalmology, Glaucoma, Rare diseases |
Status | Grant |
Latest Radiance Therapeutics News
Mar 16, 2023
EMERYVILLE, Calif.--(BUSINESS WIRE)--Radiance Therapeutics, Inc. (RadianceTx®), an innovation leader in ophthalmic devices, is delighted to announce that its CEO, Laurence Marsteller, MSc. MD, will be representing the company at the LSI USA '23 Emerging Medtech Summit, which will take place on March 20-23, 2023 in Dana Point, California. LSI USA ‘23 is a unique conference that brings together the most innovative emerging medtech players, accredited investors, and strategics looking for partners
Radiance Therapeutics Frequently Asked Questions (FAQ)
When was Radiance Therapeutics founded?
Radiance Therapeutics was founded in 2018.
Where is Radiance Therapeutics's headquarters?
Radiance Therapeutics's headquarters is located at 7440 N Oracle Rd, Tucson.
What is Radiance Therapeutics's latest funding round?
Radiance Therapeutics's latest funding round is Debt - II.
How much did Radiance Therapeutics raise?
Radiance Therapeutics raised a total of $14.01M.
What products does Radiance Therapeutics offer?
Radiance Therapeutics's products include RadianceTx’s Beta Ophthalmic System®.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
